Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 05/01/17

Julie Rhie, Ph.D., R.Ph.

Julie Rhie

Pharmacologist, Senior Regulatory Affairs Scientist

Julie Rhie joined the Regulatory Affairs Branch in 2001. Her role within RAB includes acting as a regulatory liaison for CTEP with the FDA and as an internal regulatory policy advisor. She received her Doctorate in Pharmaceutics from the University of Michigan specializing in oral absorption pharmacokinetics. Prior to joining RAB, Dr. Rhie was a Pharmacologist with the Developmental Therapeutics Program, DCTD, NCI and an NIGMS Pharmacology Research Associate Fellow where she was involved in research and regulatory review at CBER, FDA.

About the Branch Chief

Bhanu Ramineni, M.S., M.S. Bhanu Ramineni, M.S., M.S., became the Chief of the Regulatory Affairs Branch in October 2019. She joined the Drug Regulatory Group in the branch in 2010. She holds two Master's degrees: one in Environmental Sciences from Nagarjuna University, India, and a second one in Biochemistry and Molecular Biology with a specialization in Biotechnology from Georgetown University. Ms. Ramineni comes with significant experience in FDA Regulatory Affairs, as well as preclinical and clinical development of vaccines with a special focus in immunology. More…